Targeting glutamate signalling in depression: progress and prospects
Targeting glutamate signalling in depression: progress and prospects
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Key Points
Depression is one of the leading causes of disability worldwide; however, no truly mechanistically novel compounds have come to the market in decades.
Ignited by the observation of a rapid antidepressant effect of the glutamate
N
-methyl-
D
-aspartate (NMDA) receptor antagonist ketamine, the glutamate system has emerged...
Alternative Titles
Full title
Targeting glutamate signalling in depression: progress and prospects
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1878822195
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1878822195
Other Identifiers
ISSN
1474-1776
E-ISSN
1474-1784
DOI
10.1038/nrd.2017.16
